Recombinant hepatitis A virus antigen: Improved production and utility in diagnostic immunoassays

Journal of Clinical Microbiology

Volumn 36, Issue 7, 1998, Pages 2014-2018

  LaBrecque, F D ^a   LaBrecque, D R ^a   Klinzman, D ^a   Perlman, S ^a   Cederna, J B ^a   Winokur, P L ^a   Han, J Q ^b   Stapleton, J T ^a  

^a UNIVERSITY OF IOWA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS A; HEPATITIS A VIRUS; IMMUNOASSAY; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; TISSUE CULTURE; VIRUS DETECTION; VIRUS PARTICLE; VIRUS RECOMBINATION;

ANIMALIA; HEPATITIS A VIRUS; VACCINIA; VACCINIA VIRUS;

EID: 0031862378     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.7.2014-2018.1998     Document Type: Article

References (40)

1. Alonso, J. M., J. Rodriguez, E. Vinjuela, G. Kroemer, and C. Martinez. 1991. Highly efficient expression of proteins encoded by recombinant vaccinia virus in lyphocytes. Scand. J. Immunol. 34:619-626.
2. Anderson, D. A., and B. C. Ross. 1990. Morphogenesis of hepatitis A virus: isolation and characterization of subviral particles. J. Virol. 64:5284-5289.
3. Andre, F. E., A. Hepburn, and E. D'Hondt. 1990. Inactivated candidate vaccines for hepatitis A. Prog. Med. Virol. 37:72-95.
4. Borovec, S. V., and D. A. Anderson. 1993. Synthesis and assembly of hepatitis A virus-specific proteins in BS-C-1 cells. J. Virol. 67:3095-3102.
5. Cederna, J. B., D. Klinzman, and J. T. Stapleton. Hepatitis A virus (HAV) specific cellular immune responses following immunization with an inactivated vaccine. Submitted for publication.
6. Cederna, J. B., and J. T. Stapleton. 1995. Hepatitis A virus, p. 1025-1032. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. ASM Press, Washington, D.C.
7. Cohen, J. I., J. R. Ticehurst, R. H. Purcell, A. Buckler-White, and B. M. Baroudy. 1987. Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses. J. Virol. 61:50-59.
8. Coulepis, A. G., S. A. Locarnini, E. G. Westaway, G. A. Tannock, and I. D. Gust. 1982. Biophysical and biochemical characterization of hepatitis A virus. Intervirology 18:107-127.
9. Daemer, R. J., S. M. Feinstone, I. D. Gust, and R. H. Purcell. 1981. Propagation of human hepatitis A virus in African green monkey kidney cell culture: primary isolation and serial passage. Infect. Immun. 32:388-393.
10. Ellerbeck, E. F., J. A. Lewis, D. Nalin, K. Gershman, W. J. Miller, M. E. Armstrong, J. P. Davide, A. E. Rhoad, B. McGuire, G. Calandra, P. J. Provost, and K. Midthun. 1992. Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis A. Vaccine 10:668-672.
11. Flehmig, B. 1980. Hepatitis A-virus in cell culture. I. Propagation of different hepatitis A virus isolates in a fetal rhesus monkey kidney cell line (Frhk-4). Med. Microbiol. Immunol. 168:239-248.
12. Gauss-Muller, V., F. Lottspeich, and F. Deinhardt. 1986. Characterization of hepatitis A virus structural proteins. Virology 155:732-736.
13. Gauss-Muller, V., M. Q. Zhou, K. von der Helm, and F. Deinhardt. 1990. Recombinant proteins VP1 and VP3 of hepatitis A virus prime for neutralizing response. J. Med. Virol. 31:277-283.
14. Gerety, R. J., L. A. Smallwood, J. S. Finlayson, and E. Tabor. 1983. Standardization of the antibody to hepatitis A virus (anti-HAV) content of immunoglobulin. Dev. Biol. Stand. 54:411-416.
15. Johnston, J. M., S. A. Harmon, L. N. Binn, O. C. Richards, E. Ehrenfeld, and D. F. Summers. 1988. Antigenic and immunogenic properties of a hepatitis A virus capsid protein expressed in Escherichia coli. J. Infect. Dis. 157:1203-1211.
16. Karayiannis, P., S. O'Rourke, M. J. McGarvey, S. Luther, J. Waters, R. Goldin, and H. C. Thomas. 1991. A recombinant vaccinia virus expressing hepatitis A virus structural polypeptides: characterization and demonstration of protective immunogenicity. J. Gen. Virol. 72:2167-2172.
17. Lemon, S. M., and J. T. Stapleton. 1994. Prevention of hepatitis A, p. 61-79. In A. J. Zuckerman and H. C. Thomas (ed.), Viral hepatitis. Churchill Livingstone, London, United Kingdom.
18. McLinden, J., J. Stapleton, and E. Rosen. 1991. Anti-HAV neutralizing antibodies made to antigens produced by recombinant baculoviruses, p. 239-244. In H. Ginsberg, F. Brown, R. A. Lerner, and R. Chanock (ed.), Vaccines 91: modern approaches to new vaccines. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
19. Miller, M. J. 1993. Summary of current nomenclature, taxonomy, and classification of various microbial agents. Clin. Infect. Dis. 16:597-615.
20. Ostermayr, R., K. von der Helm, V. Gauss-Muller, E. L. Winnacker, and F. Deinhardt. 1987. Expression of hepatitis A virus cDNA in Escherichia coli: antigenic VP1 recombinant protein. J. Virol. 61:3645-3647.
21. Paoletti, E., H. Rosemond-Hornbeak, and B. Moss. 1974. Two nucleic acid-dependent nucleoside triphosphate phosphohydrolases from vaccinia virus: purification and characterization. J. Biol. Chem. 249:3273-3280.
22. Powdrill, T. F., and J. M. Johnston. 1991. Immunologic priming with recombinant hepatitis A virus proteins produced in Escherichia coli. J. Virol. 65:2686-2690.
23. Provost, P. J., and M. R. Hilleman. 1979. Propagation of human hepatitis A virus in cell culture in vitro. Proc. Soc. Exp. Biol. Med. 160:213-221.
24. Robertson, B. H., X.-Y. Jia, H. Tian, H. S. Margolis, D. F. Summers, and E. Ehrenfeld. 1992. Serological approaches to distinguish immune response to hepatitis A vaccine and natural infection. Vaccine 10(Suppl. 1):S106-S109.
25. Robertson, B. H., X.-Y. Jia, H. Tian, H. S. Margolis, D. F. Summers, and E. Ehrenfeld. 1993. Antibody response to nonstructural proteins of hepatitis A virus following infection. J. Med. Virol. 40:76-82.
26. Rosen, E., J. T. Stapleton, and J. McLinden. 1993. Synthesis of immunogenic hepatitis A virus particles by recombinant baculoviruses. Vaccine 11:706-712.
27. Ruchti, F., G. Siegl, and M. Weitz. 1991. Identification and characterization of incomplete hepatitis A virus particles. J. Gen. Virol. 72:2159-2166.
28. Schmidt, W. N., P. Wu, J.-Q. Han, M. J. Perino, D. R. LaBrecque, and J. T. Stapleton. 1997. Distribution of hepatitis C virus (HCV) RNA in whole blood and blood cell fractions: plasma HCV RNA analysis underestimates circulating virus load. J. Infect. Dis. 176:20-26.
29. Stapleton, J. T. 1992. Passive imunization against hepatitis A. Vaccine 10: S45-S47.
30. Stapleton, J. T., J. Frederick, and B. Meyer. 1991. Hepatitis A virus attachment to cultured cell lines. J. Infect. Dis. 164:1098-1103.
31. Stapleton, J. T., R. Jansen, and S. M. Lemon. 1985. Neutralizing antibody to hepatitis A virus in immune serum gobulin and in the sera of human recipients of immune serum globulin. Gastroenterology 89:637-642.
32. Stapleton, J. T., D. K. Lange, J. W. LeDuc, L. N. Binn, R. W. Jansen, and S. M. Lemon. 1991. The role of secretory immunity in hepatitis A virus infection. J. Infect. Dis. 163:7-11.
33. Stapleton, J. T., and S. M. Lemon. 1987. Neutralization escape mutants define a dominant immunogenic neutralization site on hepatitis A virus. J. Virol. 61:491-498.
34. Stapleton, J. T., and S. M. Lemon. 1997. New vaccines against hepatitis A, p. 571-585. In M. M. Levine, G. C. Woodrow, J. B. Kaper, and G. S. Cobon (ed.), New generation vaccines. Marcel Dekker, Inc., New York, N.Y.
35. Stapleton, J. T., V. Raina, P. L. Winokur, K. Walters, D. Klinzman, E. Rosen, and J. H. McLinden. 1993. Antigenic and immunogenic properties of recombinant hepatitis A virus 14S and 70S subviral particles. J. Virol. 67: 1080-1085.
36. Stapleton, J. T., E. Rosen, and J. McLinden. 1991. Detection of hepatitis A virus capsid proteins in insect cells infected with recombinant baculoviruses encoding the entire hepatitis A virus open reading frame, p. 50-54. In F. B. Hollinger, S. M. Lemon, and H. S. Margolis (ed.), Viral hepatitis and liver disease. The Williams & Wilkins Co., Baltimore, Md.
37. Stewart, D. R., T. S. Morris, R. H. Purcell, and S. U. Emerson. 1997. Detection of antibodies to the nonstructural 3C proteinase of hepatitis A virus. J. Infect. Dis. 176:593-601.
38. Winokur, P. L., J. H. McLinden, and J. T. Stapleton. 1991. The hepatitis A virus polyprotein expressed by a recombinant vaccinia virus undergoes proteolytic processing and assembly into virus-like particles. J. Virol. 65:5029-5036.
39. Winokur, P. L., and J. T. Stapleton. 1992. Immunoglobulin prophylaxis for hepatitis A. Clin. Infect. Dis. 14:580-586.
40. Wunschmann, S., A. Vallbracht, B. Flehmig, P. Winokur, D. Klinzman, and J. T. Stapleton. 1998. Cytolytic T lymphocyte epitopes are present on hepatitis A virus structural proteins. In M. Rizzeto (ed.), Viral hepatitis and liver disease, in press.